Wen Shuhao, Xtalpi's cofounder and chairman, speaks at the company's IPO ceremony in Hong Kong on June 13, 2024. Shanshan Kao/Forbes Asia ByZinnia Lee, Forbes Staff. I cover successful ...
Speaking at a panel in Davos on Tuesday, Hudson said Sanofi uses AI to recommend whether drugs should "pass through a tollgate," or essentially get approval to move to the next phase of development.
Isomorphic Labs aims to start clinical trials for AI-designed drugs by year-end, potentially revolutionizing drug discovery timelines. Market optimism persists under Trump 2.0, with a focus on big ...